Hepdecide: A standards-oriented, explainable clinical decision support prototype for the chronic liver-disease spectrum—design, guideline-grounded reporting, and a leakage-controlled retrospective evaluation

dc.authorid0000-0001-9840-4211
dc.contributor.authorTokatlı, Nazlı
dc.date.accessioned2026-10-12T12:09:47Z
dc.date.available2026-10-12T12:09:47Z
dc.date.issued2026
dc.departmentFakülteler, Mühendislik ve Doğa Bilimleri Fakültesi, Bilgisayar Mühendisliği Bölümü
dc.description.abstractBackground/Objectives: Specialist hepatology capacity is small relative to the population needing assessment, so most decisions about whom to investigate for chronic liver disease fall to non-specialists guided by static laboratory indices reported in isolation. This study presents HepDecide, a standards-oriented decision support prototype consolidating stage specific risk estimation, explainability and guideline-traceable reporting into one physician facing service, and reports a leakage-controlled retrospective evaluation of its predictive layer. Methods: HepDecide combines stage-specific tabular classifiers, an explainability layer based on SHapley Additive exPlanations (SHAP), and retrieval-augmented genera tion (RAG) anchored to EASL and AASLD guidelines; outputs are expressed as HL7 FHIR R4 resources, with inputs mapped to LOINC and diseases to ICD-10. Three endpoints were modelled on two publicly available, de-identified cohorts: steatohepatitis versus simple steatosis and histological cirrhosis (F4) in a biopsy-characterised MASLD cohort (n = 605), and one-year survival among patients with hepatocellular carcinoma (HCC; n = 165). Because patient-level predictions from the original development runs were not retained, the primary evaluation is a separate re-analysis with a locked patient-wise test partition, imputation, scaling and resampling fitted within training folds only, 25 classifier–imbalance configurations per endpoint, training-only calibration, and calibration, precision–recall, decision-curve and SHAP analyses. Results: On the locked test partitions, ROC-AUC was 0.67 (95% CI 0.50–0.84) for steatohepatitis (n = 121), 0.81 (0.52–1.00) for cirrhosis (n = 121; five events) and 0.76 (0.56–0.92) for one-year HCC survival (n = 33), with Brier scores of 0.096, 0.028 and 0.199. On the same cirrhosis test partition FIB-4 reached an ROC-AUC of 0.92 (0.82–0.99). The five highest-ranked SHAP features accounted for 58–73% of total attribution. Development-phase estimates of 0.90, 0.98 and 0.92 are reported separately as archived values; the cirrhosis estimate is documented in a retained training output, although its original input tables and individual test probabilities are unavailable. No quantitative evaluation of the language-generation layer is claimed, because the corre sponding records were not retained. Conclusions: Under leakage-controlled retrospective conditions the predictive layer showed moderate discrimination with wide confidence intervals and did not outperform FIB-4 for cirrhosis. The value of the prototype lies in its standards-oriented, explainable and guideline-grounded design and in a fully docu mented, reproducible evaluation pipeline; transportability, the text-generation layer and clinical usefulness remain to be established prospectively. HepDecide is intended as a clinician-supervised triage and reporting prototype, not a clinically ready system.
dc.identifier.citationTokatlı, N. (2026). Hepdecide: A standards-oriented, explainable clinical decision support prototype for the chronic liver-disease spectrum—design, guideline-grounded reporting, and a leakage-controlled retrospective evaluation. Healthcare, 14(20), pp. 1-33. https://doi.org/10.3390/healthcare14203397
dc.identifier.doi10.3390/healthcare14203397
dc.identifier.endpage33
dc.identifier.issn2227-9032
dc.identifier.issue20
dc.identifier.scopusqualityQ1
dc.identifier.startpage1
dc.identifier.urihttps://doi.org/10.3390/healthcare14203397
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1664
dc.identifier.volume14
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.indekslendigikaynak.otherSCI-E - Science Citation Index Expanded
dc.indekslendigikaynak.otherSSCI - Social Science Citation Index
dc.institutionauthorTokatlı, Nazlı
dc.institutionauthorid0000-0001-9840-4211
dc.language.isoen
dc.publisherMDPI Publishing
dc.relation.ispartofHealthcare
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectClinical Decision Support Systems
dc.subjectHealth Informatics
dc.subjectDigital Health
dc.subjectHL7 FHIR
dc.subjectInteroperability
dc.subjectExplainable Artificial Intelligence
dc.subjectLarge Language Models
dc.subjectRetrieval-Augmented Generation
dc.subjectRetrospective Evaluation
dc.subjectCalibration
dc.subjectChronic Liver Disease
dc.titleHepdecide: A standards-oriented, explainable clinical decision support prototype for the chronic liver-disease spectrum—design, guideline-grounded reporting, and a leakage-controlled retrospective evaluation
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text.pdf
Boyut:
4.7 MB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: